Dyne Therapeutics Inc.

DYN | NASDAQ

Price Alert Chart Builder DCF Calculator

$17.12

+$0.01 (+0.06%)

At close: Sep 21, 2026, 4:00 PM ET

$18.44

+$1.32 (+7.71%)

Pre-market: Sep 22, 2026, 8:42 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $3.2B

Enterprise Value $2.32B

Beta 1.08

Average Volume 1.99M

Shares Outstanding (Diluted) 165.45M

Shares Change YoY 45.29%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US26818M1080

Price Performance

Price Change 1M -34.1%

Price Change 3M -15.5%

Price Change 6M -9.8%

Price Change YTD -7.5%

Price Change 1Y 27.4%

Price Change 3Y 88.3%

Price Change 5Y 4.3%

1M CAGR (ann.) -34.8%

1Y CAGR (ann.) 23.0%

5Y CAGR (ann.) 1.5%

All-Time CAGR -5.4%

Valuation

PE Ratio -5.14

Forward PE N/A

PEG Ratio -0.36

Forward PEG 0.71

PS Ratio N/A

Forward PS 60.50

PB Ratio 4.55

P/FCF Ratio -6.40

P/Adj. FCF Ratio -5.94

P/OCF Ratio -5.92

EV/Sales N/A

EV/EBIT -4.66

EV/EBITDA -4.68

EV/FCF -4.64

Earnings Yield -19.4%

FCF Yield -15.6%

Adj. FCF Yield -16.8%

Financial Health

Net Cash $878.6M

Total Debt $19.87M

Cash & Short-Term Investments $898.48M

Total Assets $994.01M

Current Ratio 12.02

Quick Ratio 12.02

Debt / Equity Ratio 0.03

Debt / EBITDA -0.04

Debt / FCF -0.04

OCF / Debt -24.05

Interest Coverage -36.05

Altman Z-Score 3.57

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -7.9%

Returns

Return on Assets -52.3%

Return on Equity -64.3%

Return on Invested Capital -58.3%

Return on Capital Employed -58.6%

Return on Tangible Assets -52.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -48.0%

EPS CAGR 3Y 3.6%

EPS CAGR 5Y -0.4%

EPS CAGR 10Y 1.9%

FCF CAGR 3Y -38.7%

FCF CAGR 5Y -32.2%

FCF CAGR 10Y -74.5%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 14

EPS Growth Next 3Y 21.3%

Revenue Growth Next 3Y N/A

Earnings Date Nov 3, 2026

EPS Estimate (next Q) -$0.88

EPS Growth Est (next Q) 15.8%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $33.71

Price Target Upside 96.9%

Cash Flow

Operating Cash Flow $-477.82M

Free Cash Flow $-499.22M

Adj. Free Cash Flow $-538.51M

FCF Per Share -$3.02

OCF Per Share -$2.89

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-521K

Operating Income $-536.96M

EBITDA $-495.35M

Net Income $-519.41M

EPS (Diluted) -$3.33

Revenue / Employee N/A

Profit / Employee $-1.8M

Employees 289